Anika Therapeutics (ANIK) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.10 +1.25%
Financial Fact:
Comprehensive income (loss): 9.26M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Comprehensive income (loss): 9.26M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.37, $0.01 worse than the analyst estimate of $0.38. Revenue for the quarter came in at $23.4 million versus the consensus estimate of $23.89 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance
- Autodesk (ADSK) Tops Q2 EPS by 18c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
